Phase II Trial of Gemcitabine plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Ovarian Cancer Patients

Author： Nagourney R.A.   Brewer C.A.   Radecki S.   Kidder W.A.   Sommers B.L.   Evans S.S.   Minor D.R.   DiSaia P.J.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.88, Iss.1, 2003-01, pp. : 35-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up

By Morgan R.J.   Braly P.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Najera L.   Johnson D.   Doroshow J.H.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 433-438

Elsevier

Access to resources Recommend Favorite

Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer

By Hensley Martee  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 51-52

Informa Healthcare

Access to resources Recommend Favorite

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

By Lam Elaine   Au Jessie   Otterson Gregory   Guillaume Wientjes M.   Chen Ling   Shen Tong   Wei Yong   Li Xiaobai   Bekaii-Saab Tanios   Murgo Anthony   Jensen Rhonda   Grever Michael   Villalona-Calero Miguel  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1019-1029

Springer Publishing Company

Access to resources Recommend Favorite

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

By Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 419-426

Elsevier

Access to resources Recommend Favorite